Re:Pfizer and BioNTech launch trial of Omicron-targeted Covi...
by nradov on Tuesday January 25, 2022 @03:17PM
(#30077462)
If you're going to state vaccine effectiveness percentages then you need to define the endpoint. Stating that it provides 40% protection against Omicron is meaningless. Is that against PCR confirmed infection, symptomatic infection, hospitalization, death, or something else? And over what time period?
The reality is that two doses of the existing mRNA vaccines still provide very good protection against severe disease for the vast majority of patients.
The reality is that two doses of the existing mRNA vaccines still provide very good protection against severe disease for the vast majority of patients.
https://peterattiamd.com/covid-part2/